Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PDEX
STRONG BUYFLAGPro-Dex, Inc. · Healthcare · United States · $175M · Avg Vol: $5M/d
Pro-Dex has strong quality at Q75 and momentum M66, but value at V44 is below the calibrated floor, so stage one fails. Insider selling of 0.31% is separately adverse.
COMPANY DESCRIPTION
Pro-Dex, Inc. is a specialized manufacturer of powered surgical instruments for medical device OEMs, including robotic surgical systems, and rotary handpieces for dental applications. The company's competitive edge stems from its deep expertise in high-precision, miniature powered rotary instruments, coupled with strong engineering capabilities and a track record of quality and reliability. Pro-Dex serves as a critical, niche supplier within the medical and dental industries, leveraging its specialized manufacturing and development capabilities.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42.0M | 46.1M | 53.8M | 66.6M | 16.6% | 74.6M | 76.4M | 81.0M | 10.3% |
| EPS | 1.06 | 1.98 | 0.61 | 2.73 | 37.1% | 3.47 | — | — | — |
| Shares | 3.6M | 3.5M | 3.4M | 3.3M | -9.3% | 3.2M | — | — | — |
| Debt | 16.0M | 14.8M | 13.5M | 16.6M | 1.3% | 20.2M | — | — | — |
| Equity | 25.4M | 31.6M | 30.9M | 36.6M | 12.9% | — | — | — | — |
| Op CF | -0.8M | 5.5M | 6.2M | -1.7M | 14.0% | 7.3M | — | — | — |
| Inv CF | -1.2M | -0.9M | -2.2M | -0.2M | — | — | — | — | — |
| Fin CF | -0.8M | -2.5M | -4.3M | -0.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PDEX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PDEX | Pro-Dex, Inc.(you) | $175M | 91 | STRONG BUY |
| UTMD | Utah Medical Products, Inc. | $214M | 96 | STRONG BUY |
| EMBC | Embecta Corp. | $195M | 74 | BUY |
| SMTI | Sanara MedTech Inc. | $234M | 60 | HOLD |
| OSUR | OraSure Technologies, Inc. | $273M | 48 | HOLD |
| ANGO | AngioDynamics, Inc. | $562M | 58 | HOLD |
| KRMD | KORU Medical Systems, Inc. | $176M | 26 | SELL |
| NVST | Envista Holdings Corporation | $4.3B | 89 | STRONG BUY |
| LMAT | LeMaitre Vascular, Inc. | $2.2B | 75 | BUY |
| DXR | Daxor Corporation | $61M | 43 | HOLD |
Peer medians: ROE -25.6% · P/E 27.9x · Gross margin 50.7%